Drugs / CM559
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07175506 | Sep 2025 → Jun 2026 overdue | — | Keymed Biosciences Co.Ltd | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CM559 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07175506 ↗ |
| Route | Intravenous | “CM559 injection administered IV, once.” NCT07175506 ↗ |